MedPath

ovel Empowering Solutions and Technologies for Older people to Retain Everyday life activities

Completed
Conditions
General prevention for maintaining health
maintaining independence
prevention
Registration Number
NL-OMON49714
Lead Sponsor
Preventie Collectief VOF
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
13
Inclusion Criteria

Age: between 65 and 75 years.
Community dwelling, living in their own home.
Independent for all instrumental activities of Lawton & Brody index (phone use,
shopping, preparing meals, housekeeping, laundry, transportation, use of
medication, handle finances)
Physically high functioning, with at least a score of 9+ points in the Short
Physical Performance Battery.
Preserved cognition, with at least a score of 24 points in the Mini Mental
State Examination (MMSE).
Able to use information and communication technology devices. With enough
skills to install apps and shoot pictures in a smartphone.
Availability of the minimum technical system requirements at home: WIFI
connection and a tablet or smartphone with Android 7.0 or newer and Bluetooth
connectivity.
Voluntarily agreeing to participate providing informed consent.

Exclusion Criteria

Persons involved in another clinical trial.
Persons reporting deficient vision.
Persons reporting deficient hearing.
Presence of 2 or more symptoms of the Geriatric Depression Scale.
Presence of the following chronic conditions diagnosed by a doctor:
cardiovascular, metabolic, neurologic, immunologic, respiratory, kidney
diseases or diabetes in treatment with insulin. Note: Persons with hypertension
under pharmacological control, hypercholesterolemia, hypertriglyceridemia,
arthrosis, diabetes not treated with insulin, osteoporosis or constipation can
participate in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Feasibility assessment is done with log files reporting number, type, severity<br /><br>and cause of each problem encountered. Usability and Acceptance assessment is<br /><br>done with the score on respectively the System Usability Scale and the<br /><br>Technology Acceptance Model for the complete NESTORE Platform and for each<br /><br>single component in the different phases of use: Installation, Set-up, First<br /><br>use, Extended use. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>For Feasibility, the secondary outcome is related to the preliminary assessment<br /><br>of efficacy, i.e. the possible improvement in the NESTORE well-being domains.<br /><br><br /><br>For Usability, the secondary outcome is assumed to be the rate of users<br /><br>willingly to continue the intervention after the study (assessed 2 weeks after<br /><br>the conclusion of the study).<br /><br><br /><br>For Acceptance, the secondary outcome measures are:<br /><br>- the drop-out rate (% of users abandoning the study because of lost interest)<br /><br>- the rate of users continuing the intervention after the study (assessed 2<br /><br>weeks after the conclusion of the study).</p><br>
© Copyright 2025. All Rights Reserved by MedPath